Spain· ES:1231756001
INAQOVI 35 MG/100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
A medicinal product containing decitabina + cedazuridina, registered in Spain by Otsuka Pharmaceutical Netherlands B.V..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- decitabina + cedazuridina
- Manufacturer
- Otsuka Pharmaceutical Netherlands B.V.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Decitabina + cedazuridina in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaINQOVITAIHO PHARMA CANADA, INC.
- CzechiaINAQOVIOtsuka Pharmaceutical Netherlands B.V., Amsterdam
- FinlandInaqoviOtsuka Pharmaceutical Netherlands B.V.
- United KingdomInaqovi 35mg/100mg tabletsOtsuka Pharmaceuticals (U.K.) Ltd
- IrelandInaqovi 35 mg/100 mg film-coated tabletsOtsuka Pharmaceutical Netherlands B.V.
- IcelandInaqoviOtsuka Pharmaceutical Netherlands B.V.*
- NetherlandsInaqovi 35 mg/100, fimomhulde tablettenOtsuka Pharmaceutical Netherlands B.V.
- NorwayInaqoviOtsuka Pharmaceutical Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Inaqovi
- Liechtenstein · Inaqovi
- Norway · Inaqovi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/df9e350b-21e9-4f97-a52a-88985c36b03c GET /v1/drugs/df9e350b-21e9-4f97-a52a-88985c36b03c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Diagnóstico Hospitalario",
"estado": "{\"aut\":1697541085000}",
"nregistro": "1231756001",
"substance": "decitabina + cedazuridina"
}See everything about decitabina + cedazuridina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.